Loading quotes...

Forecast

Buy	0
Hold	1
Sell	1

News Go to news feed

Novonesis raises outlook for 2026 — shares jump 8.5%

Novonesis reported organic revenue growth of 8% in the first half (Q2: 9%) and adjusted earnings per share of €1.09 (+9%). Management raised the full-year guidance for organic growth to 7–8% and signalled that the adjusted EBITDA margin is likely to be at the upper end of the 37–38% range. The company also announced a €1 billion share buyback program, the planned acquisition of MicroBioGen, and an interim dividend of 2.35 DKK. The stock rose 8.5% after the figures and traded near its 52-week high. » More on de.investing.com
Novonesis reports Q1 growth of 7% and confirms full-year outlook

Novonesis reported organic revenue growth of 7% in the first quarter of 2026, with revenue of €1,119.3m; adjusted EBITDA margin fell slightly from 38.3% to 37.8%, mainly due to currency effects and strategic market exits. Both divisions (Food & Health and Planetary Health) contributed to growth, with innovation and inventory build supporting volumes. The company completed a €1.7bn bond issuance, significantly increased operating cash flow and raised adjusted earnings per share. Management confirmed the 2026 guidance, forecasting organic revenue growth of 5–7% and an adjusted EBITDA margin of 37–38%. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Novonesis has already paid €0.88 in dividends. The last payout was in August.

Financials

In the last quarter, Novonesis had revenue of €1.11bn and net profit of €170.97m

(EUR)	June 2026	YoY
Revenue	1.11bn	9.14%
Gross profit	619.07m	13.71%
Net profit	170.97m	25.00%
EBITDA	413.05m	13.68%

Fundamentals

Metric	Value
Market capitalization	€25.37bn
Number of shares	412.53m
52-week high/low	€65.15 - €46.51
Dividend yield	1.37%
Dividends TTM	€0.88
Beta	0.62
P/E ratio	45.49
PEG ratio	1.90
P/B ratio	2.66
P/S ratio	6.11

Company profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.